Herein we provide evidence that expression levels of isoforms of HSP90 bear prognostic value in ACC patients and that targeting HSP90 function has therapeutic potential resulting in consistent anti-tumor effects in different cell systems of adrenocortical cancer origin. The gene discussed is HSP90AB1; the disease is neoplasm.